SynthesisDrug design, development and therapy2015

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.

Lijun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.